Wockhardt Limited (WOCKPHARMA.BO)
INR 1450.6
(0.36%)
INR 1450.6
(0.36%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 250 Million | 1.53 Billion | 4.13 Billion | -2.87 Billion | 6.48 Billion | 1.83 Billion |
| Net Income | -4.63 Billion | -6.24 Billion | -4.11 Billion | 9.16 Billion | -1.96 Billion | -3 Billion |
| Depreciation & Amortization | 2.23 Billion | 2.51 Billion | 2.47 Billion | 2.46 Billion | 2.25 Billion | 1.66 Billion |
| Deferred income taxes | - | 770 Million | -820 Million | -15.21 Billion | -68.8 Million | -105.6 Million |
| Stock-based compensation | 10 Million | 10 Million | 10 Million | 20 Million | 22.6 Million | 15.8 Million |
| Change in working capital | -80 Million | 1.53 Billion | 3.67 Billion | -1.43 Billion | 3.79 Billion | 802.9 Million |
| Other non-cash items | 5.69 Billion | 2.95 Billion | 2.91 Billion | 2.13 Billion | 2.44 Billion | 2.46 Billion |
| Investing Cash Flow | -1.4 Billion | -1.25 Billion | -2.01 Billion | 14.7 Billion | -1.55 Billion | 945.7 Million |
| Investments in PPE | -2.16 Billion | -2.09 Billion | -2.12 Billion | -1.66 Billion | -1.72 Billion | -2.74 Billion |
| Acquisitions | 660 Million | 790 Million | 10 Million | 15.35 Billion | 89.4 Million | 53.7 Million |
| Investment purchases | - | - | -980 Million | -96 Million | -1.34 Billion | 153.9 Million |
| Sales/Maturities of investments | 100 Million | - | 70 Million | 356 Million | 4.3 Million | 2.13 Billion |
| Other Investing Activities | 100 Million | 50 Million | 1.01 Billion | 750 Million | 1.42 Billion | 1.35 Billion |
| Financing Cash Flow | 5.31 Billion | -3.15 Billion | -710 Million | -11.71 Billion | -6.79 Billion | -7.76 Billion |
| Debt repayment | -1.43 Billion | -4.06 Billion | -20.88 Billion | -9.55 Billion | -8.81 Billion | -8.19 Billion |
| Dividends payments | - | - | -20 Million | -5.3 Million | - | -200 Thousand |
| Common Stock Repurchased | - | - | - | -3.54 Billion | - | -2.71 Billion |
| Common Stock Issuance | 4.67 Billion | -30 Million | 7.48 Billion | 200 Thousand | 300 Thousand | 200 Thousand |
| Other Financing Activities | 4.02 Billion | 940 Million | 12.71 Billion | 1.38 Billion | 2.02 Billion | 3.14 Billion |
| Accounts receivables | 1.42 Billion | 1.99 Billion | 70 Million | 3.46 Billion | 534.5 Million | -2.93 Billion |
| Accounts payables | - | - | - | 9.1 Million | -100 Thousand | 2.93 Billion |
| Inventory | 80 Million | 1.41 Billion | 300 Million | -1.07 Billion | 1.29 Billion | 363.5 Million |
| Other working capital | -1.58 Billion | -1.87 Billion | 3.3 Billion | -3.83 Billion | 1.96 Billion | 437.9 Million |
| Cash at beginning of period | 940 Million | 3.7 Billion | 2.32 Billion | 2.19 Billion | 3.97 Billion | 8.97 Billion |
| Cash at end of period | 5.29 Billion | 900 Million | 3.7 Billion | 2.32 Billion | 2.19 Billion | 3.97 Billion |
| Capital Expenditure | -2.16 Billion | -2.09 Billion | -2.12 Billion | -1.66 Billion | -1.72 Billion | -2.74 Billion |
| Effect of forex changes on cash | -10 Million | 70 Million | -30 Million | 10 Million | 81.5 Million | -13.5 Million |
| Net cash flow / Change in cash | 4.35 Billion | -2.8 Billion | 1.38 Billion | 130 Million | -1.78 Billion | -4.99 Billion |
| Free Cash Flow | -1.91 Billion | -560 Million | 2.01 Billion | -4.53 Billion | 4.76 Billion | -915.5 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.63 Billion | -830 Million | -770 Million | -1.34 Billion | -6.24 Billion | -2.08 Billion |
| Depreciation & Amortization | 2.23 Billion | 550 Million | 550 Million | 550 Million | 2.51 Billion | 560 Million |
| Deferred income taxes | - | - | - | - | 770 Million | - |
| Stock-based compensation | 10 Million | - | - | - | 10 Million | - |
| Change in working capital | -80 Million | - | - | - | 1.53 Billion | - |
| Other non-cash items | 5.69 Billion | 1.38 Billion | -550 Million | -550 Million | 2.95 Billion | -560 Million |
| Investing Cash Flow | -1.4 Billion | - | - | - | -1.25 Billion | - |
| Investments in PPE | -2.16 Billion | - | - | - | -2.09 Billion | - |
| Acquisitions | 660 Million | - | - | - | 790 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 100 Million | - | - | - | - | - |
| Other Investing Activities | 100 Million | - | - | - | 50 Million | - |
| Financing Cash Flow | 5.31 Billion | - | - | - | -3.15 Billion | - |
| Debt repayment | -1.43 Billion | - | - | - | -4.06 Billion | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.67 Billion | - | - | - | -30 Million | - |
| Other Financing Activities | 4.02 Billion | - | - | - | 940 Million | - |
| Accounts receivables | 1.42 Billion | - | - | - | 1.99 Billion | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 80 Million | - | - | - | 1.41 Billion | - |
| Other working capital | -1.58 Billion | - | - | - | -1.87 Billion | - |
| Cash at beginning of period | 940 Million | 840 Million | 1.61 Billion | 940 Million | 3.7 Billion | 3.02 Billion |
| Cash at end of period | 5.29 Billion | 1.94 Billion | 840 Million | -1.34 Billion | 900 Million | 940 Million |
| Capital Expenditure | -2.16 Billion | - | - | - | -2.09 Billion | - |
| Effect of forex changes on cash | -10 Million | - | - | - | 70 Million | - |
| Net cash flow / Change in cash | 4.35 Billion | 1.1 Billion | -770 Million | -2.28 Billion | -2.8 Billion | -2.08 Billion |
| Free Cash Flow | -1.91 Billion | 1.1 Billion | -770 Million | -1.34 Billion | -560 Million | -2.08 Billion |
603390
0L8B
HSIC
QYBX
FSC
MME